HER2 aptamer-conjugated iron oxide nanoparticles with PDMAEMA-b-PMPC coating for breast cancer cell identification
Article in Nanomedicine (January 2024)
The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.
Targeting triple-negative breast cancer cells with a β1-integrin binding aptamer
Article in Molecular Therapy - Nucleic Acids (August 2023)
Iron Oxide Nanoparticles Coated with Biodegradable Block-Copolymer PDMAEMA-b-PMPC and Functionalized with Aptamer for HER2 Breast Cancer Cell Identification
Preprint in bioRxiv (June 2023)